Breast cancer was diagnosed in more than 220,000 women in 2011. Find out in which five states a breast cancer diagnosis is the most common, as well as what current and developing therapies are being used to treat this terrible disease.

While the S&P Biotech index soars, ImmunoGen shareholders are getting left in the dust. Find out what's been holding shares back in 2014, and whether or not ImmunoGen will rebound from its current price.